优化心力衰竭患者指南指导下的医疗处方率的数字化解决方案:ESC 电子心脏病学工作组、欧洲心脏病学会心力衰竭协会、欧洲心脏病学会心血管护理及相关专业协会、ESC 数字健康委员会、ESC 心肿瘤理事会和 ESC 患者论坛的临床共识声明。

IF 3.9 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS European heart journal. Digital health Pub Date : 2024-08-30 eCollection Date: 2024-11-01 DOI:10.1093/ehjdh/ztae064
Mark Johan Schuuring, Roderick Willem Treskes, Teresa Castiello, Magnus Thorsten Jensen, Ruben Casado-Arroyo, Lis Neubeck, Alexander R Lyon, Nurgul Keser, Marcin Rucinski, Maria Marketou, Ekaterini Lambrinou, Maurizio Volterrani, Loreena Hill
{"title":"优化心力衰竭患者指南指导下的医疗处方率的数字化解决方案:ESC 电子心脏病学工作组、欧洲心脏病学会心力衰竭协会、欧洲心脏病学会心血管护理及相关专业协会、ESC 数字健康委员会、ESC 心肿瘤理事会和 ESC 患者论坛的临床共识声明。","authors":"Mark Johan Schuuring, Roderick Willem Treskes, Teresa Castiello, Magnus Thorsten Jensen, Ruben Casado-Arroyo, Lis Neubeck, Alexander R Lyon, Nurgul Keser, Marcin Rucinski, Maria Marketou, Ekaterini Lambrinou, Maurizio Volterrani, Loreena Hill","doi":"10.1093/ehjdh/ztae064","DOIUrl":null,"url":null,"abstract":"<p><p>The 2021 European Society of Cardiology guideline on diagnosis and treatment of acute and chronic heart failure (HF) and the 2023 Focused Update include recommendations on the pharmacotherapy for patients with New York Heart Association (NYHA) class II-IV HF with reduced ejection fraction. However, multinational data from the EVOLUTION HF study found substantial prescribing inertia of guideline-directed medical therapy (GDMT) in clinical practice. The cause was multifactorial and included limitations in organizational resources. Digital solutions like digital consultation, digital remote monitoring, digital interrogation of cardiac implantable electronic devices, clinical decision support systems, and multifaceted interventions are increasingly available worldwide. The objectives of this Clinical Consensus Statement are to provide (i) examples of digital solutions that can aid the optimization of prescription of GDMT, (ii) evidence-based insights on the optimization of prescription of GDMT using digital solutions, (iii) current evidence gaps and implementation barriers that limit the adoption of digital solutions in clinical practice, and (iv) critically discuss strategies to achieve equality of access, with reference to patient subgroups. Embracing digital solutions through the use of digital consults and digital remote monitoring will future-proof, for example alerts to clinicians, informing them of patients on suboptimal GDMT. Researchers should consider employing multifaceted digital solutions to optimize effectiveness and use study designs that fit the unique sociotechnical aspects of digital solutions. Artificial intelligence solutions can handle larger data sets and relieve medical professionals' workloads, but as the data on the use of artificial intelligence in HF are limited, further investigation is warranted.</p>","PeriodicalId":72965,"journal":{"name":"European heart journal. Digital health","volume":"5 6","pages":"670-682"},"PeriodicalIF":3.9000,"publicationDate":"2024-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11570396/pdf/","citationCount":"0","resultStr":"{\"title\":\"Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum.\",\"authors\":\"Mark Johan Schuuring, Roderick Willem Treskes, Teresa Castiello, Magnus Thorsten Jensen, Ruben Casado-Arroyo, Lis Neubeck, Alexander R Lyon, Nurgul Keser, Marcin Rucinski, Maria Marketou, Ekaterini Lambrinou, Maurizio Volterrani, Loreena Hill\",\"doi\":\"10.1093/ehjdh/ztae064\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The 2021 European Society of Cardiology guideline on diagnosis and treatment of acute and chronic heart failure (HF) and the 2023 Focused Update include recommendations on the pharmacotherapy for patients with New York Heart Association (NYHA) class II-IV HF with reduced ejection fraction. However, multinational data from the EVOLUTION HF study found substantial prescribing inertia of guideline-directed medical therapy (GDMT) in clinical practice. The cause was multifactorial and included limitations in organizational resources. Digital solutions like digital consultation, digital remote monitoring, digital interrogation of cardiac implantable electronic devices, clinical decision support systems, and multifaceted interventions are increasingly available worldwide. The objectives of this Clinical Consensus Statement are to provide (i) examples of digital solutions that can aid the optimization of prescription of GDMT, (ii) evidence-based insights on the optimization of prescription of GDMT using digital solutions, (iii) current evidence gaps and implementation barriers that limit the adoption of digital solutions in clinical practice, and (iv) critically discuss strategies to achieve equality of access, with reference to patient subgroups. Embracing digital solutions through the use of digital consults and digital remote monitoring will future-proof, for example alerts to clinicians, informing them of patients on suboptimal GDMT. Researchers should consider employing multifaceted digital solutions to optimize effectiveness and use study designs that fit the unique sociotechnical aspects of digital solutions. Artificial intelligence solutions can handle larger data sets and relieve medical professionals' workloads, but as the data on the use of artificial intelligence in HF are limited, further investigation is warranted.</p>\",\"PeriodicalId\":72965,\"journal\":{\"name\":\"European heart journal. Digital health\",\"volume\":\"5 6\",\"pages\":\"670-682\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2024-08-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11570396/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European heart journal. Digital health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/ehjdh/ztae064\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European heart journal. Digital health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ehjdh/ztae064","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

欧洲心脏病学会关于急慢性心力衰竭(HF)诊断和治疗的 2021 年指南和 2023 年重点更新指南包括对射血分数降低的纽约心脏病协会(NYHA)II-IV 级 HF 患者的药物治疗建议。然而,来自 EVOLUTION HF 研究的多国数据发现,在临床实践中,指南指导的药物治疗(GDMT)存在严重的处方惰性。原因是多方面的,包括组织资源的限制。数字化解决方案,如数字化会诊、数字化远程监护、数字化心脏植入式电子设备检查、临床决策支持系统和多方面干预等,在全球范围内日益普及。本临床共识声明旨在提供:(i)有助于优化 GDMT 处方的数字化解决方案实例;(ii)使用数字化解决方案优化 GDMT 处方的循证见解;(iii)限制临床实践中采用数字化解决方案的现有证据差距和实施障碍;以及(iv)针对患者亚群,批判性地讨论实现平等获取的策略。通过使用数字会诊和数字远程监控来采用数字解决方案将有利于未来的发展,例如向临床医生发出警报,告知他们正在接受次优 GDMT 治疗的患者。研究人员应考虑采用多方面的数字解决方案来优化效果,并使用适合数字解决方案独特社会技术方面的研究设计。人工智能解决方案可以处理更大的数据集,减轻医疗专业人员的工作量,但由于人工智能在高频中的应用数据有限,因此还需要进一步研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum.

The 2021 European Society of Cardiology guideline on diagnosis and treatment of acute and chronic heart failure (HF) and the 2023 Focused Update include recommendations on the pharmacotherapy for patients with New York Heart Association (NYHA) class II-IV HF with reduced ejection fraction. However, multinational data from the EVOLUTION HF study found substantial prescribing inertia of guideline-directed medical therapy (GDMT) in clinical practice. The cause was multifactorial and included limitations in organizational resources. Digital solutions like digital consultation, digital remote monitoring, digital interrogation of cardiac implantable electronic devices, clinical decision support systems, and multifaceted interventions are increasingly available worldwide. The objectives of this Clinical Consensus Statement are to provide (i) examples of digital solutions that can aid the optimization of prescription of GDMT, (ii) evidence-based insights on the optimization of prescription of GDMT using digital solutions, (iii) current evidence gaps and implementation barriers that limit the adoption of digital solutions in clinical practice, and (iv) critically discuss strategies to achieve equality of access, with reference to patient subgroups. Embracing digital solutions through the use of digital consults and digital remote monitoring will future-proof, for example alerts to clinicians, informing them of patients on suboptimal GDMT. Researchers should consider employing multifaceted digital solutions to optimize effectiveness and use study designs that fit the unique sociotechnical aspects of digital solutions. Artificial intelligence solutions can handle larger data sets and relieve medical professionals' workloads, but as the data on the use of artificial intelligence in HF are limited, further investigation is warranted.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.00
自引率
0.00%
发文量
0
期刊最新文献
Introducing online multi-language video animations to support patients' understanding of cardiac procedures in a high-volume tertiary centre. Deep-learning-driven optical coherence tomography analysis for cardiovascular outcome prediction in patients with acute coronary syndrome. Validation of machine learning-based risk stratification scores for patients with acute coronary syndrome treated with percutaneous coronary intervention. On the detection of acute coronary occlusion with the miniECG. Cardiac anatomic digital twins: findings from a single national centre.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1